Glutamate-based Therapies for Psychiatric Disorders

Nonfiction, Health & Well Being, Psychology, Psychiatry, Medical, Medical Science, Pharmacology
Cover of the book Glutamate-based Therapies for Psychiatric Disorders by , Birkhäuser Basel
View on Amazon View on AbeBooks View on Kobo View on B.Depository View on eBay View on Walmart
Author: ISBN: 9783034602419
Publisher: Birkhäuser Basel Publication: September 7, 2010
Imprint: Birkhäuser Language: English
Author:
ISBN: 9783034602419
Publisher: Birkhäuser Basel
Publication: September 7, 2010
Imprint: Birkhäuser
Language: English

Both metabotropic and ionotropic glutamate receptors present attractive “druggable” targets in treating disorders of the central nervous system. There has been a dramatic shift in the focus of glutamate-based therapies away from neurologic disorders such as stroke and traumatic brain injury to the treatment of psychiatric disorders. This “Milestones in Drug Therapy” volume offers a unique, contemporary overview of preclinical and clinical evidence that modulating glutamatergic tone is an effective means of treating psychiatric disorders ranging from depression and anxiety to schizophrenia and drug abuse. The ability to treat diseases such as depression and schizophrenia through multiple, glutamate-based mechanisms offers a unique therapeutic opportunity, as described in this book.

View on Amazon View on AbeBooks View on Kobo View on B.Depository View on eBay View on Walmart

Both metabotropic and ionotropic glutamate receptors present attractive “druggable” targets in treating disorders of the central nervous system. There has been a dramatic shift in the focus of glutamate-based therapies away from neurologic disorders such as stroke and traumatic brain injury to the treatment of psychiatric disorders. This “Milestones in Drug Therapy” volume offers a unique, contemporary overview of preclinical and clinical evidence that modulating glutamatergic tone is an effective means of treating psychiatric disorders ranging from depression and anxiety to schizophrenia and drug abuse. The ability to treat diseases such as depression and schizophrenia through multiple, glutamate-based mechanisms offers a unique therapeutic opportunity, as described in this book.

More books from Birkhäuser Basel

Cover of the book Non-Opioid Analgesics in the Treatment of Acute Pain by
Cover of the book Clinical and Biological Basis of Lung Cancer Prevention by
Cover of the book Cancer and Inflammation by
Cover of the book Cytokines and Joint Injury by
Cover of the book Rock Friction and Earthquake Prediction by
Cover of the book Deep Earth Electrical Conductivity by
Cover of the book Seismic Waves in Laterally Inhomogeneous Media Part II by
Cover of the book HMG-CoA Reductase Inhibitors by
Cover of the book Rhinitis: Immunopathology and Pharmacotherapy by
Cover of the book Mycorrhizal Technology in Agriculture by
Cover of the book Changing Things — Moving People by
Cover of the book Shallow Subduction Zones: Seismicity, Mechanics and Seismic Potential by
Cover of the book Monitoring the Comprehensive Nuclear-Test-Ban Treaty: Data Processing and Infrasound by
Cover of the book Hierarchic Recognition of Tumors in Chest Radiographs with Computer by
Cover of the book Alzheimer Disease by
We use our own "cookies" and third party cookies to improve services and to see statistical information. By using this website, you agree to our Privacy Policy